Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score N/A
- Piotroski Score N/A
- Grade Neutral
- Symbol (IDRA)
- Company Idera Pharmaceuticals, Inc.
- Price $0.43
- Changes Percentage (-23.04%)
- Change -$0.13
- Day Low $0.42
- Day High $0.51
- Year High $16.00
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors, squamous cell carcinoma of the head and neck, and colorectal cancer. The company has a collaboration agreement with Bristol-Meyers Squibb. Idera Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Exton, Pennsylvania.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) N/A
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Buy
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.00
- Trailing P/E Ratio 0
- Forward P/E Ratio 0
- P/E Growth 0
- Net Income $-23,360,000
Income Statement
Quarterly
Annual
Latest News of IDRA
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
TCL QM7 4K TV review: Our favorite midrange QLED for a bright, bold picture
Business Insider may earn commissions through links. The TCL 2024 QM7 QLED TV offers great features at an affordable price, with impressive brightness and HDR performance. While not perfect, its value...
By Business Insider | 1 month ago -
The Hisense U8N is the midrange TV most people should buy in 2024 | CNN Underscored
The Hisense U8N Mini-LED ULED 4K Google TV stands out as an exceptional value with great picture quality, performance, and features for its price of around $1,000....
By CNN | 2 months ago -
As the AI boom gobbles up power, Phaidra is helping companies manage datacenter power more efficiently
Goldman Sachs predicts data centers will consume 8% of U.S. power by 2030, up from 3% in 2022. Phaidra, an AI startup, retrofits data centers for energy efficiency. With $60....
By Yahoo! Finance | 3 months ago